The first-ever pill for postpartum depression has been given the greenlight in America following a successful clinical trial. Zuranolone, the new pill, which is sold under the brand name Zurzuvae, has been approved by the Food and Drug Administration (FDA) as a once-daily pill taken for two weeks. Until now the only available treatment for … Continue reading New pill approved to tackle postpartum depression